Desk›Healthcare› Sanofi India Ltd
Sanofi India Ltd
BSE 500674 · NSE SANOFI · ISIN INE058A01010 · Group A · Active
Healthcare › Healthcare › Pharmaceuticals & Biotechnology › Pharmaceuticals
₹3,181.15
-0.29%
BSE close, 28 August 2026
₹7,326.19 cr
2.3 cr shares · Small cap
₹2,884.93 cr
as published
22.6× · 8.51×
EPS ₹140.60 · BV ₹373.81
1,837.40 / 326.70
₹ cr, as filed
34
10 selected · 29%
Reg 30
Sch. III Part A
Price 52-week, BSE
| Against 52-week high | -38.8% |
|---|---|
| Against 52-week low | +4.0% |
| Day change | -0.29% |
| Size band | Small cap |
| Index membership | None |
Valuation as published by BSE
| Earnings per share | ₹140.60 |
|---|---|
| Price / earnings | 22.63× |
| Price / book | 8.51× |
| Book value — derived, price ÷ P/B | ₹373.81 |
| Return on equity | 37.62% |
| Operating margin | 27.76% |
| Net margin | 19.08% |
Consistency check
- P/B ÷ P/E, which must equal ROE
- 37.60%
- ROE as published
- 37.62%
Results ₹ crore, as filed
RevenueNet profit one scale across all three periods, ₹ crore
| Period | Revenue ₹cr | Net profit ₹cr | EPS ₹ | OPM | NPM |
|---|---|---|---|---|---|
| Jun-26 · Q | 437.70 | 83.50 | 36.26 | 27.76% | 19.08% |
| Mar-26 · Q | 472.30 | 102.60 | 44.55 | 31.17% | 21.72% |
| FY25-25 | 1,837.40 | 326.70 | 141.85 | 26.33% | 17.78% |
Quarter on quarter
- Revenue, quarter on quarter
- -7.3%
- Net profit, quarter on quarter
- -18.6%
- Operating margin, quarter on quarter
- -341 bps
Disclosure profile 34 filings in the window
| Tag | Filings |
|---|---|
| Selected | |
| Change in Management | 2 |
| Board Outcome | 1 |
| Change in Directorate | 1 |
| Concall Transcript | 1 |
| Investor Presentation | 1 |
| KMP | 1 |
| Press Release | 1 |
| Resignation | 1 |
| Results | 1 |
| Selected sub-total | 10 |
| Procedural | |
| General | 11 |
| SAST | 6 |
| Analyst / Investor Meet | 2 |
| Board Meeting | 1 |
| Compliance Certificate | 1 |
| Insider / SAST | 1 |
| Newspaper Publication | 1 |
| Trading Window | 1 |
| Procedural sub-total | 24 |
| Total | 34 |
Disclosure regime
LODR Reg 30
Read with Schedule III Part A. An equity filer in BSE Group A, so the Regulation 30 disclosure framework and the Schedule III event list both apply.
Filing rhythm · 93 trading days
34 filings · 10 selected · busiest 2026-09-25
Filing rhythm · the twelve most recent
2026-09-252026-10-09
SelectedProcedural
Filings
34 in the window · 6 earlier on record
-
9 October 2026 ·
Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018
Kindly refer the attachment.
Company Update / Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018 View filing →
-
7 October 2026 ·
Disclosures under Reg. 10(7) of SEBI (SAST) Regulations, 2011
The Exchange has received the disclosure under Regulation 10(7) in respect of acquisition under Regulation 10(1)(a)(iii)of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, ....
Insider Trading / SAST / Disclosures under Reg. 10(7) of SEBI (SAST) Regulations, 2011 View filing →
-
29 September 2026 ·
Disclosure Under Regulation 30 Of The SEBI (Listing Obligations And Disclosure Requirements) Regulations, 2015
Kindly refer the attachment.
Company Update / General View filing →
-
28 September 2026 ·
Disclosures under Reg. 10(6) of SEBI (SAST) Regulations, 2011
The Exchange has received the disclosure under Regulation 10(6) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 for Sanofi Healthcare India Pvt Ltd
Insider Trading / SAST / Disclosures under Reg. 10(6) of SEBI (SAST) Regulations, 2011 View filing →
-
28 September 2026 ·
Disclosure Under Regulation 7(2)(B) Of The SEBI (Prohibition Of Insider Trading) Regulations, 2015
Disclosure received by the Company on 25th September 2026 under Regulation 7(2)(a) of the SEBI (Prohibition of Insider Trading) Regulations, 2015 from Sanofi Healthcare India Private Limited, ....
Company Update / General View filing →
-
28 September 2026 ·
Disclosure Under Regulation 7(2)(B) Of The SEBI (Prohibition Of Insider Trading) Regulations, 2015
Disclosure received by the Company on 25th September 2026 under Regulation 7(2)(a) of the SEBI (Prohibition of Insider Trading) Regulations, 2015 from Hoechst GmbH, a promoter of the Company
Company Update / General View filing →
-
25 September 2026 ·
Disclosure Under Regulation 30 Of The SEBI (Listing Obligations And Disclosure Requirements) Regulations, 2015
Kindly refer the attachment
Company Update / General View filing →
-
25 September 2026 ·
Disclosures under Reg. 29(2) of SEBI (SAST) Regulations, 2011
The Exchange has received the disclosure under Regulation 29(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 for Hoechst GmbH & PACs
Insider Trading / SAST / Disclosures under Reg. 29(2) of SEBI (SAST) Regulations, 2011 View filing →
-
25 September 2026 ·
Disclosures under Reg. 29(2) of SEBI (SAST) Regulations, 2011
The Exchange has received the disclosure under Regulation 29(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 for Sanofi Healthcare India Pvt Ltd & PACs
Insider Trading / SAST / Disclosures under Reg. 29(2) of SEBI (SAST) Regulations, 2011 View filing →
-
25 September 2026 ·
Disclosures under Reg. 29(1) of SEBI (SAST) Regulations, 2011
The Exchange has received the disclosure under Regulation 29(1) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 for Sanofi Healthcare India Pvt Ltd & PACs
Insider Trading / SAST / Disclosures under Reg. 29(1) of SEBI (SAST) Regulations, 2011 View filing →
-
25 September 2026 ·
Disclosures under Reg. 29(2) of SEBI (SAST) Regulations, 2011
The Exchange has received the disclosure under Regulation 29(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 for Hoechst GmbH & PACs
Insider Trading / SAST / Disclosures under Reg. 29(2) of SEBI (SAST) Regulations, 2011 View filing →
-
25 September 2026 ·
Closure of Trading Window
Kindly refer the attachment.
Insider Trading / SAST / Closure of Trading Window View filing →
-
21 September 2026 ·
Disclosure Under Regulation 30 Of The Securities And Exchange Board Of India (Listing Obligations And Disclosure Requirements) Regulations, 2015
Kindly refer the attachment
Company Update / General View filing →
-
18 September 2026 ·
Disclosures under Reg. 10(5) in respect of acquisition under Reg. 10(1)(a) of SEBI (SAST) Regulations, 2011
The Exchange has received the disclosure under Regulation 10(5) in respect of acquisition under Regulation 10(1)(a) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, ....
Insider Trading / SAST / Disclosures under Reg. 10(5) in respect of acquisition under Reg. 10(1)(a) of SEBI (SAST) Reg. 2011 View filing →
-
8 September 2026 ·
Disclosure Under Regulation 30 Of The SEBI (Listing Obligations And Disclosure Requirements) Regulations, 2015
Kindly refer the attachment
Company Update / General View filing →
-
31 August 2026 ·
Disclosure Under Regulation 30 Of The SEBI (Listing Obligations And Disclosure Requirements) Regulations, 2015 - Receipt Of Show Cause Notice From GST Authorities
Kindly refer the attachment
Company Update / General View filing →
-
13 August 2026 ·
Disclosure Under Regulation 30 Of The SEBI (Listing Obligations And Disclosure Requirements) Regulations, 2015
Kindly refer the attachment
Company Update / General View filing →
-
11 August 2026 ·
Disclosure Under Regulation 30 Of The SEBI (Listing Obligations And Disclosure Requirements) Regulations, 2015
Kindly refer the attachment
Company Update / General View filing →
-
10 August 2026 ·
Earnings Call Transcript
Kindly refer the attachment.
Company Update / Earnings Call Transcript View filing →
-
6 August 2026 ·
Analyst / Investor Meet - Outcome
Kindly refer the attachment
Company Update / Analyst / Investor Meet View filing →
-
5 August 2026 ·
Newspaper Publication
Kindly refer the attachment
Company Update / Newspaper Publication View filing →
-
5 August 2026 ·
Investor Presentation
Kindly refer the attachment
Company Update / Investor Presentation View filing →
-
4 August 2026 ·
Intimation Under Regulation 30(5) Of The Listing Regulations
Kindly refer the attachment
Company Update / General View filing →
-
4 August 2026 ·
Re-Constitution Of The Committees Of The Company
Kindly refer the attachment
Company Update / General View filing →
-
4 August 2026 ·
Press Release / Media Release
Kindly refer the attachment
Company Update / Press Release / Media Release View filing →
-
4 August 2026 ·
Board Meeting Outcome for Unaudited Financial Results For The Quarter And Half Year Ended 30Th June 2026
Kindly refer the attachment
Board Meeting / Outcome of Board Meeting View filing →
-
4 August 2026 ·
Unaudited Financial Results For The Quarter And Half Year Ended 30Th June 2026
Kindly refer the attachment
Result / Financial Results View filing →
-
31 July 2026 ·
Change in Management
Kindly refer the attachment
Company Update / Change in Management View filing →
-
23 July 2026 ·
Analyst / Investor Meet - Intimation
Kindly refer the attachment.
Company Update / Analyst / Investor Meet View filing →
-
23 July 2026 ·
Resignation of Director
Kindly refer the attachment
Company Update / Resignation of Director View filing →
-
23 July 2026 ·
Resignation of Chief Financial Officer (CFO)
Kindly refer the attachment
Company Update / Resignation of Chief Financial Officer (CFO) View filing →
-
23 July 2026 ·
Change in Management
Kindly refer the attachment
Company Update / Change in Management View filing →
-
23 July 2026 ·
Change in Directorate
Kindly refer the attachment
Company Update / Change in Directorate View filing →
-
20 July 2026 ·
Board Meeting Intimation for Considering And Approving The Unaudited Financial Results For The Quarter And Half Year Ended 30Th June 2026.
Sanofi India Ltd has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 04/08/2026 ,inter alia, to consider and approve the Unaudited Financial Results ....
Board Meeting / Board Meeting View filing →
RSS feed for Sanofi India Ltd · the 50 most recent filings